Clinical Trial Update: The Use of Low Molecular Weight Heparin in Hemodiafiltration [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update on the use of low molecular weight heparin during hemodiafiltration in patients with chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Low molecular weight heparin (low molecular weight heparin)

Snippet

Sponsor: University Hospital, Ghent | Conditions: Chronic Kidney Disease | Phase 4 | Status: COMPLETED